Market Place
Sourcing Support
GSK`s asthma drug Nucala meets main goal in study on treating smoker`s lungs
06 Sep 2024 //
REUTERS
GSK`s asthma drug Nucala meets main goal in study on treating smoker`s lungs
05 Sep 2024 //
REUTERS
GSK`s Nucala Approved In Japan For Chronic Rhinosinusitis With Polyps
29 Aug 2024 //
PHARMABIZ
GSK pulls 2 Nucala batches in Taiwan over glass particle fears
18 Jul 2023 //
FIERCE PHARMA
China National Medical Products Administration accepts submission for Nucala
14 Mar 2023 //
PRESS RELEASE
GlaxoSmithKline`s Generic Nucala (Mepolizumab) Receives Approval in the U.S.
22 Jan 2022 //
FDA
GSK’s Nucala gets EU approval for eosinophil-driven diseases
18 Nov 2021 //
PHARMABIZ
Euro Roundup: CHMP recommends drugs from Biogen & Roche, knocks back Pfizer
23 Sep 2021 //
RAPS
CHMP recommends Nucala for three new indications
22 Sep 2021 //
PHARMATIMES
EMA recommends GSK’s Nucala approval in 3 additional eosinophil-driven diseases
20 Sep 2021 //
PHARMABIZ
GSK receives CHMP positive opinions recommending approval of Nucala
17 Sep 2021 //
PRESS RELEASE
NUCALA (mepolizumab) approved in Canada
15 Sep 2021 //
PRESS RELEASE
Glaxosmithkline Biological Mepolizumab Receives Approval in US
29 Jul 2021 //
FDA
NICE green light for GSK`s Nucala
02 Feb 2021 //
PHARMATIMES
FDA accepts GSK’s filing of Nucala for use inchronic rhinosinusitis nasal polyps
09 Dec 2020 //
PRESS RELEASE
FDA accepts GSK’s filing of Nucala for use in chronic rhinosinusitis
08 Dec 2020 //
PRESS RELEASE
GSK Nucala (mepolizumab) filings accepted by European Medicines Agency
30 Oct 2020 //
GSK
FDA Approvals Roundup: Nucala, Fetroja, Xeljanz
30 Sep 2020 //
RAPS
GSK’s Nucala approved in the US for hypereosinophilic syndrome
29 Sep 2020 //
PHARMA TIMES
Glaxosmithkline LLC`s Biological Mepolizumab Receives Approval In US
28 Sep 2020 //
FDA
GSK`s Nucala receives US FDA approval to treat Hypereosinophilic syndrome
28 Sep 2020 //
PRESS RELEASE
Glaxosmithkline`s Biological Mepolizumab Receives Approval In US
25 Sep 2020 //
FDA
FDA Approves Nucala as the First and Only Biologic Treatment for HES
25 Sep 2020 //
BUSINESSWIRE
FDA Approves 1st Drug to Treat Group of Rare Blood Disorders in Nearly 14 Years
25 Sep 2020 //
PRNEWSWIRE
FDA grants priority review of Nucala for patients Hypereosinophilic Syndrome
27 May 2020 //
PHARMACEUTICAL-BUSINESS
GSK adds to its trove of positive data for multiple myeloma contender as rivals
27 May 2020 //
ENDPTS
GSK signs $231M Samsung deal to expand biologics manufacturing
23 May 2020 //
FIERCE PHARMA
GSK books 19% sales growth for first quarter
29 Apr 2020 //
PHARMATIMES
GSK`s Nucala scores Dupixent-hunting trial win in nasal polyps
06 Apr 2020 //
FIERCE PHARMA
GSK`s asthma biologic Nucala is one step closer to approval in key chronic
03 Apr 2020 //
ENDPTS
GSK`s Nucala shows up Fasenra with rare disease data win
14 Nov 2019 //
FIERCE PHARMA
Enforcement Report - Week of October 2, 2019
02 Oct 2019 //
FDA
GSK`s Nucala cuts asthma attacks in interim real-world data
01 Oct 2019 //
FIERCE PHARMA
Glaxosmithkline Nucala (Mepolizumab) Receives Supplemental Approval US
14 Sep 2019 //
FDA
Nucala receives self-administration EU approval
03 Aug 2019 //
PHARMA TIMES
European approval for two new delivery formulations of GSK`s Nucala
01 Aug 2019 //
PHARMAFILE
Sanofi & Regeneron`s Dupixent scores 3rd FDA approval
27 Jun 2019 //
FIERCE PHARMA
AstraZeneca’s COPD triplet Breztri nabs first nod from Japan
20 Jun 2019 //
FIERCE PHARMA
GlaxoSmithKline`s Nucala scores convenience boost with at-home dosing options
08 Jun 2019 //
FIERCE PHARMA
GlaxoSmithKline`s Nucala Receives Approval In US
06 Jun 2019 //
FDA
As rivals crowd in, Can Novartis` Xolair remain a blockbuster?
04 Jun 2019 //
FIERCE PHARMA
Sanofi, Regeneron dive deep on asthma in debut digital awareness campaign
04 Jun 2019 //
FIERCE PHARMA
AZ`s Fasenra benefits hold up for 2 years: analysis
20 May 2019 //
FIERCE PHARMA
NICE recommends Fasenra injection as asthma alternative
05 Jan 2019 //
PHARMA TIMES
GSK seeks US FDA approval for Nucala in with severe eosinophilic asthma
20 Nov 2018 //
PHARMABIZ
ICER On Asthma Biologics: 50%-79% Price Discounts Needed
15 Nov 2018 //
PHARMA INTEL
Roche, Novartis grab FDA OK for new version of aging blockbuster Xolair
04 Oct 2018 //
FIERCE PHARMA
GSK says U.S. FDA wants more information on pulmonary drug
08 Sep 2018 //
REUTERS
EC approves GSK`s Nucala for kids with severe asthma
31 Aug 2018 //
BIOPHARMADIVE
GSK’s Nucala approved for younger asthma patients
30 Aug 2018 //
PHARMA TIMES
GSK`s Nucala gets EMA recommendation for severe paediatric asthma
01 Aug 2018 //
PHARMABIZ
FDA panel deals a blow to GSK`s Nucala with COPD thumbs-down
26 Jul 2018 //
FIERCE PHARMA
AstraZeneca`s new launches shine in Q2 as it inches toward turnaround
26 Jul 2018 //
FIERCE PHARMA
FDA staff raises efficacy doubts on GSK`s lung disease treatment
24 Jul 2018 //
REUTERS
FDA poses tough questions for GSKs pitch to gain an approval for Nucala in COPD
23 Jul 2018 //
ENDPTS
NICE says yes to AZ’s Fasenra, but only when its GSK rival can’t be used
20 Jul 2018 //
FIERCE PHARMA
AZ writes off its second pivotal COPD trial for Fasenra, killing expansion plans
31 May 2018 //
ENDPTS
Data show ‘enduring’ benefits of GSK’s Nucala
21 May 2018 //
PHARMA TIMES
GSK reports Q1 sales decline
25 Apr 2018 //
PHARMA TIMES
